Definitive Contract HT940826CE005
- Not listed
- The Defense Health Agency awarded a $430,739.50 purchase order to Werfen USA LLC on October 1, 2024, for reagents and coagulation analyzer cost-per-test services. The contract, structured as a firm fixed-price procurement with no set-aside designation, will be performed in Bedford, Massachusetts and is scheduled for completion by September 30, 2029. Werfen USA LLC, a Bedford-based manufacturer of in vitro diagnostic equipment and laboratory reagents, will deliver coagulation testing...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, was awarded a delivery order valued at $108,657.52 by the Defense Health Agency for blood coagulation analyzer equipment and associated reagents. The contract is effective from October 1, 2025, through September 30, 2026, and carries a firm fixed-price structure with no small business set-aside designation. Performance will occur in Fayetteville, North Carolina. This delivery order likely...
- The Defense Health Agency awarded a $714.7K firm fixed-price purchase order to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, for blood coagulation testing supplies and support services. This contract, which commenced on October 1, 2020, and extends through September 30, 2025, involves the delivery of two fully automated benchtop coagulation analyzer systems capable of performing comprehensive assays including...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $58,829.39 to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents. This firm fixed-price contract, which was not set aside for small businesses, was executed on August 6, 2025, with an ultimate completion date of the same day. The award represents a task order under Werfen's existing BPA vehicle with the Defense Health Agency for the supply of specialized...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Werfen USA LLC, a for-profit limited liability company based in Bedford, Massachusetts. The contract is for the supply of a blood coagulation analyzer and related reagents, with a ceiling value of $9,687.87 and a period of performance through July 31, 2025. Werfen USA LLC is a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care...
- Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory reagents, was awarded a $403,914.14 delivery order by the Defense Health Agency for the supply of reagents and blood collection supplies. The contract, issued on October 1, 2021, has a completion date of September 30, 2026, and will be performed at Camp Lejeune, North Carolina. This delivery order is structured as a firm fixed-price contract with no small business set-aside designation and...
- The Defense Health Agency awarded Werfen USA LLC a delivery order valued at $102,874.20 under the In Vitro Diagnostics, Reagents, and Test GSA Schedule (FSS-65-VII). This firm fixed-price delivery order, designated W81K00-22-F-0069, carries an ultimate completion date of September 30, 2027, with performance to be executed in Peachtree Corners, Georgia. The contract utilized no set-aside designation, with Werfen USA LLC competing as a full-sized contractor. The award was obligated with FY26 funds...
- The Defense Health Agency awarded a $15.3K firm fixed-price Blanket Purchase Agreement (BPA) call to Werfen USA LLC for reagents for laboratory testing, with an ultimate completion date of September 30, 2025. The contract was awarded on April 24, 2025, with no small business set-aside designation. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory reagents, will perform the work at its Bedford location. This BPA call represents...
- The Defense Health Agency awarded a $64,637.68 firm fixed-price purchase order to Werfen USA LLC for ACL Elite Pro Analyzers (coagulation testing equipment) and associated reagents, test kits, and controls. The contract was awarded on September 28, 2021, with an ultimate completion date of September 27, 2022, following a solicitation posted on September 14, 2021. No small business set-aside was utilized. The place of performance is Bedford, Massachusetts, where Werfen USA LLC manufactures in...
- The Defense Health Agency awarded Werfen USA LLC a $686,054.81 firm fixed-price purchase order for coagulation testing services and supplies at Fort Liberty, North Carolina. The award, announced on August 17, 2020, follows the Army Medical Command's solicitation for reagents and automated analyzers to support ongoing coagulation testing requirements at the installation. Under the contract, Werfen USA LLC is responsible for providing all necessary personnel, equipment, maintenance,...
The Defense Health Agency awarded a definitive firm fixed-price contract to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, for the provision of coagulation analyzers and associated reagents. The contract, awarded on April 1, 2026, carries a ceiling value of $271,477.50 and extends through March 31, 2031. No set-aside designation was utilized in this procurement. Werfen USA LLC will perform the work at its facilities in Bedford, Massachusetts, supplying critical laboratory instrumentation and consumables to support diagnostic testing operations across Defense Health Agency medical treatment facilities. This award represents a continuation of Werfen's established relationship with the Defense Health Agency and broader federal healthcare ecosystem. The company maintains an extensive portfolio of federal contracts, including multiple indefinite delivery vehicles valued in the millions of dollars, primarily through the Veterans Health Administration across multiple Veterans Integrated Service Networks. Werfen's coagulation testing expertise is evidenced by prior significant awards, including a $3.7 million agreement with VISN 19 and a $3.06 million contract with VISN 15, as well as a $1.29 million blanket purchase agreement with the Defense Health Agency for automated autoimmune testing. The current contract reflects the agency's confidence in Werfen's capability to deliver specialized diagnostic equipment and reagents essential to military medical readiness and beneficiary healthcare.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/30/25 |